Middletown, DE -- (SBWIRE) -- 09/05/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Avanir Pharmaceuticals Inc (NASDAQ:AVNR), Cypress Semiconductor Corporation (NASDAQ:CY), Oclaro, Inc. (NASDAQ:OCLR), Novavax, Inc.(NASDAQ:NVAX)
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) gained volume of 3.40 million shares and the average volume of the stock remained 2.43 million shares. The 52 week range of the stock remained $2.07 - $5.75 and the day range was $5.34 - $5.75.The stock opened the session at $5.41, and closed the session at $5.66. The stock showed a positive performance of +5.11% in previous trading session. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. It primarily offers NUEDEXTA, a proprietary combination of dextromethorphan and low-dose quinidine for the treatment of pseudobulbar affect, an over-the-counter product for the treatment of cold sores.
For How Long AVNR’s Gloss will Attract Investors? Find out via this report
In previous session, Cypress Semiconductor Corporation (NASDAQ:CY) traded 3.35 million shares and the average volume of the stock remained 2.27 million shares. The 52 week range of the stock remained $8.70 - $13.41. The stock was a bull and advanced +1.08%, while its closing price stayed at $11.20. The market capitalization of the stock remained 1.67 billion. The half-yearly trend of the stock remained positive +5.96%. Cypress Semiconductor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets mixed-signal, programmable solutions, specialized semiconductor memories, and integrated semiconductor solutions.
For How Long CY will fight for Profitability? Read This Trend Analysis report
Oclaro, Inc.(NASDAQ:OCLR) volume of the stock was 3.31 million shares in the most recent session and the average volume remained 567,850.00 shares. The stock plunged -13.30% and finished the prior session at the closing price of $0.919. The stock traded 3.31 million shares in its previous trading session and its average volume remained 567,850.00 shares. Oclaro, Inc. provides optical communications and laser components, and subsystems for telecommunications, industrial, scientific, consumer electronics, and medical markets worldwide. It designs, manufactures, and markets products that generate, detect, and separate light signals in telecommunications networks.
Why Should Investors Buy OCLR After the Recent Fall? Just Go Here and Find Out
Novavax, Inc.(NASDAQ:NVAX) gained volume of 3.23 million shares and the average volume of the stock remained 2.95 million shares. The 52 week range of the stock remained $1.52 - $3.29 and the day range was $3.20 - $3.29.The stock opened the session at $3.23, and closed the session at $3.23. The stock showed a positive performance of +0.94% in previous trading session. Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on developing recombinant protein nanoparticle vaccines to address a range of infectious diseases. The company?s technology platform is based on proprietary recombinant vaccine technology that includes virus-like particles (VLPs) and recombinant protein micelle vaccines.
Why Should Investors Buy NVAX After The Recent Gain? Just Go Here and Find Out
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)